智通财经网·2026-02-27 11:43Core Viewpoint - Spring Medical (01858) reported a significant increase in revenue and net profit for the fiscal year 2025, driven by the normalization of national procurement for orthopedic consumables and steady international business expansion [1] Financial Performance - Total revenue for the year reached approximately 1.044 billion yuan, representing a year-on-year growth of 29.52% [1] - Net profit attributable to the parent company was about 272 million yuan, showing a remarkable year-on-year increase of 117.72% [1] - Basic earnings per share stood at 0.71 yuan [1] Business Growth Drivers - The growth in performance is primarily attributed to the steady increase in product sales due to the normalization of national procurement for orthopedic consumables [1] - The company has expanded its domestic business scale and market share, which has contributed to the steady improvement in profitability [1] - Continuous internationalization strategy has led to sustained business expansion in international markets, providing significant support for overall performance growth [1] Operational Efficiency - The company has focused on refined operational management and optimized operational efficiency [1] - Through large-scale production, the company has strengthened its economies of scale, resulting in significant improvements in overall operational efficiency and profitability [1]